Testing effectiveness (Phase 2)Ended earlyNCT02604212
What this trial is testing
A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection
Who this might be right for
Hepatitis B
Arrowhead Pharmaceuticals 32